Sharemaestro Newsreel

Tilray Brands Inc. stock falls Monday, underperforms market

Tilray Brands Inc. (TLRY) shares fell 3.28% on Monday, closing at $4.42. This decline occurred during a generally poor trading session, with the NASDAQ Composite Index and Dow Jones Industrial Average also experiencing drops. The stock's fall ended a two-day winning streak.

Scynexis Q2 adjusted EPS misses estimate as sales decline 82.77%

Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock

Martine Rothblatt, CEO of United Therapeutics (NASDAQ:UTHR), sold 9,500 shares of the company's stock for over $5 million, reducing her stake by 2.84%. The sale occurred on August 7th at an average price of $531.38 per share. Despite the sale, United Therapeutics beat earnings …

Hims & Hers Lowers Profit Forecast, Shares Drop

Hims & Hers Health shares are down after the telehealth firm reduced the top end of its adjusted Ebitda forecast for the full year. Madison Muller reports on "Bloomberg The Close." View Comments

Harrow (NASDAQ:HROW) Posts Quarterly Earnings Results, Misses Expectations By $0.28 EPS

Harrow (NASDAQ:HROW) reported a quarterly EPS of ($0.46), missing analysts' consensus of ($0.18) by $0.28, despite revenue of $70.66 million slightly exceeding expectations. Shares of HROW traded up 0.6% following the announcement. The company has a "Moderate Buy" consensus rating from analysts, with insider …

Insider Buying: Elanco Animal Health (NYSE:ELAN) Director Buys 10,000 Shares of Stock

Elanco Animal Health (NYSE:ELAN) Director Paul Herendeen recently purchased 10,000 shares of the company's stock for $236,800, increasing his total ownership to 111,687 shares. This insider buying follows Elanco's strong quarterly earnings report, where the company beat estimates with $0.34 EPS and saw revenue …

Prestige Consumer Executives Set for Aug. 12 Fireside Chat

Prestige Consumer Healthcare Inc. (NYSE: PBH) announced that its CFO and COO, Christine Sacco, and VP of Investor Relations, Treasury, & Business Development, Phil Terpolilli, will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on August 12, 2026, at …

Prestige Consumer Healthcare Inc. to Participate in Canaccord Genuity Annual Growth Conference

Prestige Consumer Healthcare Inc. announced that its CFO and COO, Christine Sacco, and VP of Investor Relations, Treasury, & Business Development, Phil Terpolilli, will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference. The event is scheduled for Wednesday, August …

Hims Hers Health earnings missed by $0.32, revenue topped estimates

Hims & Hers Shares Drop After Beating Revenue Forecast With $753 Million, Margins Narrow

SCYNEXIS Reports Second Quarter 2026 Financial Results and Provides Corporate Update

SCYNEXIS, Inc. (NASDAQ: SCYX) announced its second quarter 2026 financial results, highlighting a strong cash position of $71.1 million, which is expected to fund operations into 2029. The company provided updates

ELAN Stock Jumps As Earnings Beat Fuels Bullish Guidance

Hims Topples As Obesity Kingpin Hits A Snag On Weighty Second-Quarter Loss

Hims stock fell late Monday after its second-quarter loss came in bigger than expected, upsetting a sales beat. Continue Reading

Phibro Animal Health CFO David Glenn Awarded 3,334 RSUs on August 6, 2026

David Glenn, CFO of Phibro Animal Health Corp (NASDAQ: PAHC), was awarded 3,334 restricted stock units (RSUs) of Class A Common Stock on August 6, 2026. The filing for this acquisition was made on August 10, 2026, with the RSUs valued at $0.

Phibro Animal Health (PAHC) awards 3,522 RSUs to Chief Operating Officer

Phibro Animal Health Corp (PAHC) has granted 3,522 restricted stock units (RSUs) to its Chief Operating Officer, Larry Lee Miller. These RSUs, representing Class A Common Stock, will vest in three equal installments over three years, contingent on his continued employment. Following this grant, …

SCYNEXIS (NASDAQ:SCYX) Announces Quarterly Earnings Results, Beats Expectations By $1.14 EPS

Hims & Hers shares fall after second-quarter wider-than-expected loss

Investing.com -- Hims & Hers Health reported a wider-than-expected second-quarter loss on Monday, sending its shares down 1.5%. The company reported a loss of 37 cents per share, compared with analysts' estimate of a loss of 5 cents per share. Revenue rose 38% year …

Harrow, Inc. (HROW) stock falls on Q2 2026 Earnings

Harrow, Inc. (HROW) reported its Q2 2026 earnings, with revenue increasing by 10.9% to $70.7 million, but the company faced pressure on profitability. The operating loss widened to $11.0 million, and the net loss attributable to common shareholders was $17.3 million, resulting in a …

Hims & Hers Health Boosts Revenue Target, Swings to Second-Quarter Loss

SCYNEXIS GAAP EPS of $0.63 beats by $1.14, revenue of $0.24M beats by $0.16M

* SCYNEXIS press release [https://seekingalpha.com/pr/20613730-scynexis-reports-second-quarter-2026-financial-results-and-provides-corporate-update] (SCYX [https://seekingalpha.com/symbol/SCYX]): Q2 GAAP EPS of $0.63 beats by $1.14. * Revenue of $0.24M (-82.4% Y/Y) beats by $0.16M. * Cash, cash equivalents and investments totaled $71.1 million on June 30, 2026, compared to $56.3 million on December 31, …

Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month

Hims & Hers Health (NYSE: HIMS) grows revenue but posts sizable loss on deals

Hims & Hers Health (NYSE:HIMS) Exceeds Q2 CY2026 Expectations But Stock Drops

Hims & Hers Health (NYSE:HIMS) Exceeds Q2 CY2026 Expectations But Stock Drops Telehealth company Hims & Hers Health (NYSE:HIMS) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 38.2% year on year to $753.2 million. On top of that, next …

BRIEF-Harrow Inc Q2 Gross Margin 71%

Harrow Inc. reported a Q2 gross margin of 71%. The article is a brief financial update and directs readers to TradingView for full access to the Reuters article and other news sources.

Harrow Announces Second Quarter 2026 Financial Results

Harrow (Nasdaq: HROW) announced its second-quarter 2026 financial results, reporting a quarterly revenue of $70.7 million, a 60% sequential increase and 11% year-over-year increase. The company reiterated its full-year 2026 revenue guidance of $350 million to $365 million and Adjusted EBITDA of $80 million …

Dr. Reddy's Laboratories Ltd (RDY) Stock Analysis: Navigating A 10.69% Upside Potential Amidst Revenue Challenges

Dr. Reddy's Laboratories Ltd (RDY) presents a potential 10.69% upside for investors, operating as a significant player in the drug manufacturing industry with a market capitalization of $10.18 billion. Despite this potential and a low forward P/E ratio, the company faces challenges including a …

Takeda Pharmaceutical (TAK) holder Elaine Shannon plans sale of 20,363 ADSs

Elaine Shannon, a shareholder of Takeda Pharmaceutical Company Limited (TAK), has filed a notice of proposed sale for 20,363 American Depositary Shares (ADSs). The sale, valued at $355,334.35, is anticipated to occur on August 11, 2026, via Interactive Brokers LLC on the NYSE. These …

Hims & Hers' shift to branded obesity drugs drives wider quarterly loss

Phibro Animal Health (PAHC) grants 2,716 RSUs to director Jonathan Bendheim

Phibro Animal Health (PAHC) director Jonathan Bendheim was granted 2,716 restricted stock units (RSUs) on August 6, 2026. These RSUs represent a contingent right to receive one share of Class A Common Stock each, and they will vest in substantially equal installments on the …

Phibro Animal Health (NASDAQ: PAHC) awards 2,478 RSUs to senior legal officer

Phibro Animal Health Corp (NASDAQ: PAHC) has awarded 2,478 Restricted Stock Units (RSUs) to Judith Weinstein, its Senior Vice President and General Counsel. This grant increases her direct holdings to 5,453 shares. The RSUs will vest in substantially equal installments over three years, beginning …

Phibro Animal Health (NASDAQ: PAHC) CFO receives 3,334-share restricted stock grant

Phibro Animal Health (NASDAQ: PAHC) CFO David Glenn was granted 3,334 restricted stock units (RSUs). These RSUs, which represent Class A Common Stock, were awarded at a price of $0.00 per share and will vest in three equal annual installments starting August 1, 2026, …

Phibro Animal Health (PAHC) awards 1,547 RSUs to SVP of Human Resources

Phibro Animal Health (PAHC) awarded 1,547 restricted stock units (RSUs) to Lisa Ann Escudero, SVP of Human Resources, on August 6, 2026. These RSUs will vest in three equal installments on the first three anniversaries of August 1, 2026, contingent on her continued employment. …

Phibro Animal Health (PAHC) grants 11,699 RSUs to President and CEO

Phibro Animal Health (PAHC) reported that its President and CEO, Daniel M. Bendheim, was granted 11,699 restricted stock units (RSUs). These RSUs represent a contingent right to receive one share of Class A Common Stock each, vesting in three equal annual installments beginning August …

Phibro Animal Health (NASDAQ: PAHC) awards 1,503 RSUs to VP Finance

Phibro Animal Health Corp (NASDAQ: PAHC) has awarded its VP Finance and Treasurer, Patrick Rodriguez, 1,503 restricted stock units (RSUs) representing Class A Common Stock. These RSUs will vest in substantially equal installments over the first three anniversaries of August 1, 2026, contingent on …

Phibro Animal Health (PAHC) grants 12,103 RSUs to Executive Chairman Bendheim

Phibro Animal Health Corp. (PAHC) Executive Chairman and 10% owner Jack Bendheim was granted 12,103 restricted stock units (RSUs). These RSUs, each representing one share of Class A Common Stock, will vest in equal installments over the first three anniversaries of August 1, 2026, …

Harrow (HROW) Reports Q2 Loss, Misses Revenue Estimates

Harrow (HROW) reported a Q2 loss of $0.34 per share, missing the Zacks Consensus Estimate of a $0.23 loss, and revenues of $70.66 million, also below estimates. The company's shares have underperformed the S&P 500 this year, and its current Zacks Rank is #3 …